590 related articles for article (PubMed ID: 29562600)
1. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein.
Lin G; Zhu F; Kanaan NM; Asano R; Shirafuji N; Sasaki H; Yamaguchi T; Enomoto S; Endo Y; Ueno A; Ikawa M; Hayashi K; Yamamura O; Yen SH; Nakamoto Y; Hamano T
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769495
[TBL] [Abstract][Full Text] [Related]
4. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine induces tau hyperphosphorylation in rats.
Luo Y; Zhou X; Yang X; Wang J
Neuroreport; 2007 Dec; 18(18):2005-8. PubMed ID: 18007203
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy.
Di Meco A; Li JG; Barrero C; Merali S; Praticò D
Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles.
Li JG; Chu J; Barrero C; Merali S; Praticò D
Ann Neurol; 2014 Jun; 75(6):851-63. PubMed ID: 24644038
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
[TBL] [Abstract][Full Text] [Related]
10. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ promotes τ phosphorylation without affecting mature tangles.
Li A; Ceballos-Diaz C; DiNunno N; Levites Y; Cruz PE; Lewis J; Golde TE; Chakrabarty P
FASEB J; 2015 Oct; 29(10):4384-98. PubMed ID: 26156074
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ.
Cho JH; Johnson GV
J Biol Chem; 2004 Dec; 279(52):54716-23. PubMed ID: 15494420
[TBL] [Abstract][Full Text] [Related]
13. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone prevents tau oligomerization.
Hamano T; Shirafuji N; Makino C; Yen SH; Kanaan NM; Ueno A; Suzuki J; Ikawa M; Matsunaga A; Yamamura O; Kuriyama M; Nakamoto Y
Biochem Biophys Res Commun; 2016 Sep; 478(3):1035-42. PubMed ID: 27543203
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
16. Immunoelectron microscopic and biochemical studies of caspase-cleaved tau in a mouse model of tauopathy.
Lin WL; Dickson DW; Sahara N
J Neuropathol Exp Neurol; 2011 Sep; 70(9):779-87. PubMed ID: 21865886
[TBL] [Abstract][Full Text] [Related]
17. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
18. Multi-Vitamin B Supplementation Reverses Hypoxia-Induced Tau Hyperphosphorylation and Improves Memory Function in Adult Mice.
Yu L; Chen Y; Wang W; Xiao Z; Hong Y
J Alzheimers Dis; 2016 Aug; 54(1):297-306. PubMed ID: 27497480
[TBL] [Abstract][Full Text] [Related]
19. Elevation of pS262-Tau and Demethylated PP2A in Retina Occurs Earlier than in Hippocampus During Hyperhomocysteinemia.
Guo J; Xu C; Ni S; Zhang S; Li Q; Zeng P; Pi G; Liu E; Sun DS; Liu Y; Wang Z; Chen H; Yang Y; Wang JZ
J Alzheimers Dis; 2019; 68(1):367-381. PubMed ID: 30775994
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
Baker S; Polanco JC; Götz J
J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
